DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 59 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,826,884 | +2.8% | 7,809,852 | 0.0% | 1.89% | +7.1% |
| Q2 2023 | $93,249,633 | -0.9% | 7,809,852 | +10.9% | 1.76% | -17.4% |
| Q1 2023 | $94,133,116 | -37.9% | 7,040,622 | 0.0% | 2.13% | -30.7% |
| Q4 2022 | $151,514,185 | +7.4% | 7,040,622 | 0.0% | 3.07% | +2.2% |
| Q3 2022 | $141,024,000 | +11.9% | 7,040,622 | 0.0% | 3.01% | -10.5% |
| Q2 2022 | $126,027,000 | +109.6% | 7,040,622 | +16.2% | 3.36% | +156.1% |
| Q1 2022 | $60,116,000 | -28.2% | 6,060,090 | +22.0% | 1.31% | -11.1% |
| Q4 2021 | $83,670,000 | -29.0% | 4,965,588 | 0.0% | 1.48% | -9.7% |
| Q3 2021 | $117,833,000 | +4.2% | 4,965,588 | 0.0% | 1.63% | -10.0% |
| Q2 2021 | $113,066,000 | – | 4,965,588 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,548,403 | $54,841,633 | 43.06% |
| PATHWAY CAPITAL MANAGEMENT, LP | 995,686 | $21,427,163 | 38.24% |
| Atlas Venture Life Science Advisors, LLC | 7,568,317 | $162,870,182 | 19.62% |
| RA Capital Management | 7,040,622 | $151,514,185 | 3.07% |
| COMMODORE CAPITAL LP | 739,661 | $15,918 | 2.40% |
| GREAT POINT PARTNERS LLC | 544,451 | $11,716,586 | 2.30% |
| Nicholas Investment Partners, LP | 786,554 | $16,926,642 | 1.48% |
| Boxer Capital, LLC | 1,189,943 | $25,607,573 | 1.35% |
| Parkman Healthcare Partners LLC | 224,483 | $4,830,874 | 1.29% |
| Cheyne Capital Management (UK) LLP | 27,223 | $585,839 | 1.02% |